Yin and Yan of Cytokine Regulation in Solid Organ Graft Rejection and Tolerance

Clinics in Laboratory Medicine

Volumn 28, Issue 3, 2008, Pages 469-479

  Wadia, Persis P ^a   Tambur, Anat R ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; JANUS KINASE 3; STAT PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE RECEPTOR; IMMUNOSUPPRESSIVE AGENT;

ALLOTRANSPLANTATION; ANTIGEN PRESENTING CELL; B LYMPHOCYTE; CELL DIFFERENTIATION; CYTOKINE RELEASE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; LYMPHOCYTE; MACROPHAGE; NEUTROPHIL; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; T LYMPHOCYTE; TH1 CELL; TH2 CELL; DRUG ANTAGONISM; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ORGAN TRANSPLANTATION; PHYSIOLOGY; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

CYTOKINES; GENE EXPRESSION REGULATION; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; ORGAN TRANSPLANTATION; RECEPTORS, CYTOKINE; SIGNAL TRANSDUCTION; TRANSPLANTATION TOLERANCE;

EID: 56349143348     PISSN: 02722712     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cll.2008.08.001     Document Type: Review

References (47)

1. Josien R., Pannetier C., Douillard P., et al. Graft-infiltrating T helper cells, CD45RC phenotype, and Th1/Th2-related cytokines in donor-specific transfusion-induced tolerance in adult rats. Transplantation 60 (1995) 1131-1139
2. Horak I., Lohler J., Ma A., et al. Interleukin-2 deficient mice: a new model to study autoimmunity and self-tolerance. Immunol Rev 148 (1995) 35-44
3. Refaeli Y., Van Parijs L., London C.A., et al. Biochemical mechanisms of IL-2-regulated Fas-mediated T cell apoptosis. Immunity 8 (1998) 615-623
4. Irmler M., Thome M., Hahne M., et al. Inhibition of death receptor signals by cellular FLIP. Nature 388 (1997) 190-195
5. Li X. The common gammac-cytokines and transplantation tolerance. Cell Mol Immunol 1 (2004) 167-172
6. McLaughlin P.J., Aikawa A., Davies H.M., et al. Evaluation of sequential plasma and urinary tumor necrosis factor alpha levels in renal allograft recipients. Transplantation 51 (1991) 1225-1229
7. Heidenreich S., Lang D., Tepel M., et al. Monocyte activation for enhanced tumour necrosis factor-alpha and interleukin 6 production during chronic renal allograft rejection. Transpl Immunol 2 (1994) 35-40
8. Deng M.C., Plenz G., Labarrere C., et al. The role of IL6 cytokines in acute cardiac allograft rejection. Transpl Immunol 9 (2002) 115-120
9. Reinders M.E., Sho M., Izawa A., et al. Proinflammatory functions of vascular endothelial growth factor in alloimmunity. J Clin Invest 112 (2003) 1655-1665
10. Luscinskas F.W., Cybulsky M.I., Kiely J.M., et al. Cytokine-activated human endothelial monolayers support enhanced neutrophil transmigration via a mechanism involving both endothelial-leukocyte adhesion molecule-1 and intercellular adhesion molecule-1. J Immunol 146 (1991) 1617-1625
11. Bharat A., Narayanan K., Street T., et al. Early posttransplant inflammation promotes the development of alloimmunity and chronic human lung allograft rejection. Transplantation 83 (2007) 150-158
12. Tripp C.S., Wolf S.F., and Unanue E.R. Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist. Proc Natl Acad Sci U S A 90 (1993) 3725-3779
13. Chang C.H., Furue M., and Tamaki K. Selective regulation of ICAM-1 and major histocompatibility complex class I and II molecule expression on epidermal Langerhans cells by some of the cytokines released by keratinocytes and T cells. Eur J Immunol 24 (1994) 2889-2895
14. Sandner S.E., Clarkson M.R., Salama A., et al. Role of the programmed death-1 pathway in regulation of alloimmune responses in vivo. J Immunol 174 (2005) 3408-3415
15. Yamada J., Yoshida M., Taylor A.W., et al. Mice with Th2-biased immune systems accept orthotopic corneal allografts placed in "high risk" eyes. J Immunol 162 (1999) 5247-5255
16. Niederkorn J.Y. Immune mechanisms of corneal allograft rejection. Curr Eye Res 32 (2007) 1005-1006
17. Hargrave S., Chu Y., Mendelblatt D., et al. Preliminary findings in corneal allograft rejection in patients with keratoconus. Am J Ophthalmol 135 (2003) 452-460
18. Matzinger P. Friendly and dangerous signals: is the tissue in control?. Nat Immunol 8 (2007) 11-13
19. Schwartz R.H. T cell anergy. Annu Rev Immunol 21 (2003) 305-334
20. Schwartz R.H. Natural regulatory T cells and self-tolerance. Nat Immunol 6 (2005) 327-330
21. Monk N.J., Hargreaves R.E., Simpson E., et al. Transplant tolerance: models, concepts and facts. J Mol Med 84 (2006) 295-304
22. Kingsley C.I., Karim M., Bushell R., et al. CD25+ CD4+ regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J Immunol 168 (2002) 1080-1086
23. Onodera K., Hancock W.W., Graser E., et al. Type 2 helper T cell-type cytokines and the development of "infectious" tolerance in rat cardiac allograft recipients. J Immunol 158 (1997) 1572-1581
24. Wells A.D., Li X.C., Li Y., et al. Requirement for T-cell apoptosis in the induction of peripheral transplantation tolerance. Nat Med 5 (1999) 1303-1307
25. Dai Z., Konieczny B.T., Baddoura F.K., et al. Impaired alloantigen-mediated T cell apoptosis and failure to induce long-term allograft survival in IL-2-deficient mice. J Immunol 161 (1998) 1659-1663
26. Bushell A., Niimi M., Morris P.J., et al. Evidence for immune regulation in the induction of transplantation tolerance: a conditional but limited role for IL-4. J Immunol 162 (1999) 1359-1366
27. Li X.C., Ima A., Li Y., et al. Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. J Immunol 164 (2000) 1193-1199
28. Lu L.F., Lind E.F., Gondek D.C., et al. Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442 (2006) 997-1002
29. Kielar M.L., John R., Bennett M., et al. Maladaptive role of IL-6 in ischemic acute renal failure. J Am Soc Nephrol 16 (2005) 3315-3325
30. Yoshida S., Haque A., Mizobuchi T., et al. Anti-type V collagen lymphocytes that express IL-17 and IL-23 induce rejection pathology in fresh and well-healed lung transplants. Am J Transplant 6 (2006) 724-735
31. Chen Y., and Wood K.J. Interleukin-23 and TH17 cells in transplantation immunity: does 23+17 equal rejection?. Transplantation 84 (2007) 1071-1074
32. Witowski J., Ksiazek K., and Jorres A. Interleukin-17: a mediator of inflammatory responses. Cell Mol Life Sci 61 (2004) 567-579
33. Li J., Simeoni E., Fleury S., et al. Gene transfer of soluble interleukin-17 receptor prolongs cardiac allograft survival in a rat model. Eur J Cardiothorac Surg 29 (2006) 779-783
34. Tang J.L., Subbotin V.M., Antonysamy M.A., et al. Interleukin-17 antagonism inhibits acute but not chronic vascular rejection. Transplantation 72 (2001) 348-350
35. Antonysamy M.A., Fanslow W.C., Fu F., et al. Evidence for a role of IL-17 in organ allograft rejection: IL-17 promotes the functional differentiation of dendritic cell progenitors. J Immunol 162 (1999) 577-584
36. Romagnani P. From basic science to clinical practice: use of cytokines and chemokines as therapeutic targets in renal diseases. J Nephrol 18 (2005) 229-233
37. Moudgil A., and Puliyanda D. Induction therapy in pediatric renal transplant recipients: an overview. Paediatr Drugs 9 (2007) 323-341
38. James D.G. A new immunosuppressant: tacrolimus. Postgrad Med J 72 (1996) 586
39. Strehlau J., Pavlakis M., Lipman M., et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 94 (1997) 695-700
40. Li X.C., Roy-Chaudhury P., Hancock W.W., et al. IL-2 and IL-4 double knockout mice reject islet allografts: a role for novel T cell growth factors in allograft rejection. J Immunol 161 (1998) 890-896
41. Ruchatz H., Leung B.P., Wei X.Q., et al. Soluble IL-15 receptor alpha-chain administration prevents murine collagen-induced arthritis: a role for IL-15 in development of antigen-induced immunopathology. J Immunol 160 (1998) 5654-5660
42. Lewis E., Weiler M., Chaimovitz C., et al. Interleukin-15 is the main mediator of lymphocyte proliferation in cultures mixed with human kidney tubular epithelial cells. Transplantation 72 (2001) 886-890
43. Ku C.C., Murakami M., Sakamoto A., et al. Control of homeostasis of CD8+ memory T cells by opposing cytokines. Science 288 (2000) 675-678
44. Tellides G., and Pober J.S. Interferon-gamma axis in graft arteriosclerosis. Circ Res 100 (2007) 622-632
45. Duncan M.D., and Wilkes D.S. Transplant-related immunosuppression: a review of immunosuppression and pulmonary infections. Proc Am Thorac Soc 2 (2005) 449-455
46. O'Shea J.J., Park H., Pesu M., et al. New strategies for immunosuppression: interfering with cytokines by targeting the Jak/Stat pathway. Curr Opin Rheumatol 17 (2005) 305-311
47. Changelian P.S., Flanagan M.E., Ball D.J., et al. Prevention of organ allograft rejection by a specific Janus kinase 3 inhibitor. Science 302 (2003) 875-878